CCN1 and atherosclerosis: Since accumulating evidence highlights an important role for VSMC dysfunctions in many cardiovascular pathological conditions including atherosclerosis, arterial remodelling, hypertension, and stroke, local modulation of this newly identified signal axis (Cezanne/β-catenin/CCN1) could represent as a novel therapy for post-angioplasty restenosis and aforementioned diseases.